Today: 22 May 2026
Costco stock closes above $1,000 as BofA restarts coverage ahead of earnings
28 February 2026
2 mins read

Costco stock closes above $1,000 as BofA restarts coverage ahead of earnings

New York, February 28, 2026, 11:54 AM EST — The market has closed.

  • Costco ended Friday at $1,010.79, up 2.44%, outperforming a softer U.S. market.
  • Bank of America jumped back in with coverage, setting a Buy and a $1,185 target on Costco, highlighting the retailer’s broad pull with shoppers from every income bracket.
  • Costco’s fiscal Q2 earnings and its February sales update land March 5, setting up the next catalyst.

Costco Wholesale Corporation shares gained 2.44% Friday, closing at $1,010.79 and bucking the broader market’s decline. COST ended roughly 5% shy of its 52-week high, with volume running heavier than normal.

Costco’s next report lands in just a few days, and the stock isn’t leaving much room for error. Investors are zeroed in on traffic, pricing, and membership fees—the main gears in Costco’s profit engine—and want to see the numbers stack up.

Retailers face a packed calendar next week, as Target and Best Buy both post results March 3. Kroger and BJ’s Wholesale will follow on March 5. That lineup leaves the sector in focus right up to Friday’s U.S. payrolls release.

Bank of America resumed its coverage of Costco on Friday, tagging the retailer with a Buy and setting a $1,185 target. The note described Costco as “well positioned” in what it called a “K-shaped economy”—where affluent shoppers are still opening their wallets, but others are feeling pinched. Analyst Christopher Nardone pointed to Costco’s strategy of pricing and wage reinvestment, saying it supports customers in their “hunt for the best prices.” https://ca.investing.com/news/stock-market…

The bank, in that same note, put Walmart and Costco at the top of its picks, while taking a more bearish stance on Target. Nardone pointed to Executive memberships as a real asset, keeping an eye on how renewal rates are shaping up. He also called out e-commerce investment as a risk to watch over the medium term.

Costco is set to post its fiscal Q2 earnings report and February sales numbers at 1:15 p.m. PT on March 5, according to the company’s own calendar. The earnings call is scheduled for 2 p.m. PT.

According to Zacks estimates on Nasdaq.com, revenue is expected to hit $69.22 billion, with profit landing at $4.53 a share. Forecasts have edged up over the past month. For comparable sales growth—which excludes the impact of new locations—the estimate sits at 6.5% for the quarter.

The risk is clear enough: expectations are lofty, and so is the valuation. Costco trades at about 54 times trailing earnings, based on Investing.com’s latest EPS number. That doesn’t leave much cushion—any hit to margins or slowdown in membership-fee growth could sting.

Costco’s price discipline and focused assortment help sustain store visits, but expenses aren’t going away. If defending market share gets pricier, or membership renewal rates slip again, those developments could put pressure on a stock now trading above $1,000.

Macro risks aren’t off the table. Investors now have their eyes on the U.S. February jobs numbers, landing March 6. A Reuters poll Friday pegged forecasted job gains at 60,000—a figure that can whiplash both rate expectations and consumer stock prices.

Costco investors are circling March 5. That’s when February sales land, with a close look at same-store performance, renewal rates, and any fresh data on digital spending. What happens there will set the tone for COST—holding ground, or not, in the sessions that follow.

Stock Market Today

  • Q1 Earnings Review: Azenta Falls; West Pharmaceutical Leads Drug Development Services Stocks
    May 21, 2026, 9:31 PM EDT. Drug development inputs and services stocks, essential for pharmaceutical research and manufacturing, reported mixed Q1 results. Azenta (NASDAQ:AZTA), specializing in biological sample management, posted disappointing results with $144.8 million revenue, missing estimates and the weakest among peers, causing its share price to drop 23.4% to $17.65. Conversely, West Pharmaceutical Services (NYSE:WST), maker of specialized packaging and delivery devices, delivered a strong quarter with $844.9 million revenue, beating estimates by 8.4%. Overall, the sector's revenues beat consensus by 1.6%, despite an average 2.5% share price decline post-earnings. Tailwinds include growth in biologics and gene therapies, while headwinds feature pricing pressure and regulatory risks.

Latest articles

OpenAI Shares Hype Returns, Still No Ticker in Sight

OpenAI Shares Hype Returns, Still No Ticker in Sight

22 May 2026
OpenAI is preparing to confidentially file for a U.S. IPO, aiming to go public as early as September, sources told Reuters. The move follows a court win against Elon Musk, removing a key legal obstacle. Private-market share prices for OpenAI ranged from $658.94 to $732.38 this month, but no official public price exists. Ordinary investors still cannot buy OpenAI stock on public exchanges.
Estée Lauder Shares Gain as Rumored Deal Fails to Materialize

Estée Lauder Shares Gain as Rumored Deal Fails to Materialize

22 May 2026
Estée Lauder and Spain’s Puig ended merger talks that would have created a $40 billion beauty group. Estée Lauder shares rose about 10% in after-hours trading, closing the regular session at $78.91. The company said it will focus on its turnaround plan and continue reviewing possible acquisitions or divestitures.
WhiteFiber Stock Rips 22% on $160 Million AI Deal. The Test Comes in July

WhiteFiber Stock Rips 22% on $160 Million AI Deal. The Test Comes in July

22 May 2026
WhiteFiber shares jumped 22.2% to $29.55 after announcing a five-year AI compute contract worth over $160 million for a Paris-region deployment using NVIDIA GPU systems. Google Finance showed the stock rising further after hours. The project is backed by planned financing and 12 months of customer prepayments, but funding and execution remain pending. Service is expected to start in July, subject to equipment delivery and acceptance.
Eli Lilly stock price rebounds above $1,050 — what traders are watching next
Previous Story

Eli Lilly stock price rebounds above $1,050 — what traders are watching next

Block stock price surges after Jack Dorsey’s AI-driven layoffs — what to watch next
Next Story

Block stock price surges after Jack Dorsey’s AI-driven layoffs — what to watch next

Go toTop